Gewählte Publikation:
Pföhler, C; Ugurel, S; Seiter, S; Wagner, A; Tilgen, W; Reinhold, U.
Interferon-alpha-associated development of bullous lesions in mycosis fungoides.
Dermatology. 2000; 200(1):51-53
Doi: 10.1159/000018317
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Ugurel-Becker Selma
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We report a 67-year-old woman with mycosis fungoides (MF) who was receiving subcutaneous injections of recombinant interferon alpha-2b (IFN-alpha). After 2 months of IFN-alpha treatment, bullous lesions appeared on her trunk and extremities. A skin biopsy specimen from the trunk revealed histopathologic features of bullous MF. Bullous lesions with specific infiltrates of MF are very rare; to the best of our knowledge, this is the first case showing specific bullous lesions of MF developed under IFN-alpha treatment.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use
-
Female -
-
Humans -
-
Interferon Type I, Recombinant - adverse effects Interferon Type I, Recombinant - therapeutic use
-
Mycosis Fungoides - drug therapy
-
Skin Diseases, Vesiculobullous - chemically induced
-
Skin Neoplasms - drug therapy
- Find related publications in this database (Keywords)
-
cutaneous T cell lymphoma
-
bullous mycosis fungoides
-
interferon alpha